enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
-
Exxon, Chevron turn page on legal fight as profits slip
-
Prosecutors call for PSG's Achraf Hakimi to face rape trial
-
Missing Kenya football tickets blamed on govt protest fears
-
India's Krishna and Siraj rock England in series finale
-
Norris completes 'double top' in Hungary practice
-
MLB names iconic Wrigley Field as host of 2027 All-Star Game
-
Squiban doubles up at women's Tour de France
-
International crew bound for space station
-
China's Qin takes 'miracle' second breaststroke gold at swim worlds
-
Siraj strikes as India fight back in England finale
-
Brewed awakening: German beer sales lowest on record
-
Indonesia volcano belches six-mile ash tower
-
US promises Gaza food plan after envoy visit
-
Musk's X accuses Britain of online safety 'overreach'
-
France says it cannot save contraceptives US plans to destroy
-
Russian drone attacks on Ukraine hit all-time record in July
-
Stocks sink on Trump tariffs, US jobs data
-
Newcastle reject Liverpool bid for Isak: reports
-
Cracks emerge in US jobs market as Fed officials sound warning
-
Douglass dedicates world gold to stricken US after 'rough' week
-
Senegal PM unveils economic recovery plan based on domestic resources
-
China's Qin milks 'miracle' second breaststroke gold at swim worlds
-
Swiss will try to negotiate way out of stiff US tariffs
-
US job growth weaker than expected in July as unemployment rises
-
Miracle man Qin wins second worlds gold ahead of blockbuster
-
Budapest mayor questioned as a suspect over Pride march
-
Thai-Cambodian cyberwarriors battle on despite truce
-
UK top court to rule on multi-billion pound car loan scandal
-
World economies reel from Trump's tariffs punch
-
French wine industry warns of 'brutal' impact from US tariffs
-
England openers run riot in India finale after Atkinson strikes
-
China's Qin wins 'miracle' second breaststroke gold at swim worlds
-
US envoy visits Gaza sites as UN says hundreds of aid-seekers killed
-
Steenbergen wins world 100m freestyle to deny O'Callaghan
-
Stocks slide as Trump's new tariff sweep offsets earnings
-
HIV-positive Turkmen man fears deportation, torture
-
India collapse in England decider as Atkinson strikes
-
Outrage grows in France over US plan to destroy contraceptives
-
Rees-Zammit to return to rugby after NFL dream ends
-
England say injured Woakes set to miss rest of India decider
-
Bayer sets aside more cash to deal with weedkiller woes
-
Pakistan inflict more T20 misery on West Indies
-
South Korea's Yoon resists questioning by lying in underwear
-
Stocks drop as Trump's new tariff sweep offsets earnings
-
El Salvador abolishes presidential term limits, allowing another Bukele run
-
Nintendo quarterly revenue surges thanks to Switch 2
-
Swiss to try to negotiate way out of stiff US tariffs
-
British Airways owner sees profit jump on 'strong' demand
-
Sand and dust storm sweeps across southern Peru
-
Battered Wallabies determined to deny Lions a whitewash
NYSE - LSE
| CMSC | -0.13% | 22.82 | $ | |
| BCC | -1.17% | 82.84 | $ | |
| SCS | -1.22% | 10.205 | $ | |
| RBGPF | 0.69% | 74.94 | $ | |
| GSK | 0.57% | 37.364 | $ | |
| BTI | 1.33% | 54.405 | $ | |
| CMSD | 0.17% | 23.31 | $ | |
| NGG | 1.74% | 71.64 | $ | |
| JRI | -0.44% | 13.073 | $ | |
| SCU | 0% | 12.72 | $ | |
| RYCEF | -2.75% | 13.8 | $ | |
| BCE | 1.31% | 23.64 | $ | |
| BP | -1.34% | 31.725 | $ | |
| RELX | -0.87% | 51.44 | $ | |
| RIO | -0.47% | 59.49 | $ | |
| AZN | 0.73% | 73.63 | $ | |
| VOD | 1.1% | 10.93 | $ |
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
- Video webcast now available on-demand
IRVINE, CA / ACCESS Newswire / July 22, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Rob Berman, CEO of enVVeno, participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.
As part of the segment, Mr. Berman dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company's products in development.
The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the enVVeno website, envveno.com.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insuffihttps://virtualinvestorco.com/summer-spotlight/cy (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
M.Thompson--AMWN
